For: | Yu HC, Cheng JS, Lai KH, Lin CP, Lo GH, Lin CK, Hsu PI, Chan HH, Lo CC, Tsai WL, Chen WC. Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy. World J Gastroenterol 2005; 11(10): 1439-1444 [PMID: 15770718 DOI: 10.3748/wjg.v11.i10.1439] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i10/1439.htm |
Number | Citing Articles |
1 |
Hiroya Iida, Tsukasa Aihara, Shinichi Ikuta, Naoki Yamanaka. Comparative study of percutaneous radiofrequency ablation and hepatic resection for small, poorly differentiated hepatocellular carcinomas. Hepatology Research 2014; 44(10) doi: 10.1111/hepr.12264
|
2 |
Kenji SAKOGAWA, Mamoru OEDA, Sunao OTAGAKI, Fumio TAKAEKO. A CASE OF ASYNCHRONOUS MULTIPLE LIVER METASTASES FOLLOWING GASTRIC CANCER SURGERY TREATED USING RADIOFREQUENCY ABLATION. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2010; 71(5): 1264 doi: 10.3919/jjsa.71.1264
|
3 |
Wing‐Hong Li, Ka‐Wing Ma, Mina Cheng, King‐Him Chui, Pat‐Tat Chan, Wai‐Ho Chu, Hon‐shing Fung, Chong‐Hei Kowk, Moon‐Tong Cheung. Radiofrequency ablation for hepatocellular carcinoma: a survival analysis of 117 patients. ANZ Journal of Surgery 2010; 80(10): 714 doi: 10.1111/j.1445-2197.2010.05434.x
|
4 |
Wolf Bäumler, Lukas Philipp Beyer, Lukas Lürken, Philipp Wiggermann, Christian Stroszczynski, Marco Dollinger, Andreas Schicho. Detection of Incomplete Irreversible Electroporation (IRE) and Microwave Ablation (MWA) of Hepatocellular Carcinoma (HCC) Using Iodine Quantification in Dual Energy Computed Tomography (DECT). Diagnostics 2022; 12(4): 986 doi: 10.3390/diagnostics12040986
|
5 |
Debra A. Gervais, S. Nahum Goldberg, Daniel B. Brown, Michael C. Soulen, Steven F. Millward, Dheeraj K. Rajan. Society of Interventional Radiology Position Statement on Percutaneous Radiofrequency Ablation for the Treatment of Liver Tumors. Journal of Vascular and Interventional Radiology 2009; 20(1): 3 doi: 10.1016/j.jvir.2008.09.007
|
6 |
Brent D. Weinberg, Elvin Blanco, Jinming Gao. Polymer Implants for Intratumoral Drug Delivery and Cancer Therapy. Journal of Pharmaceutical Sciences 2008; 97(5): 1681 doi: 10.1002/jps.21038
|
7 |
Kazuki HORI, Ryojin UCHINO, Norihisa HANADA, Shuichi KUSANO. A SUCCESSFUL CASE OF RADIOFREQUENCY ABLATION FOR A METASTATIC LIVER TUMOR FROM GASTRIC CANCER AFTER CT GUIDED PERCUTANEOUS LIPIODOL INJECTION. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2007; 68(5): 1243 doi: 10.3919/jjsa.68.1243
|
8 |
Chang-Hsien Liu, Ronald S. Arellano, Raul N. Uppot, Anthony E. Samir, Debra A. Gervais, Peter R. Mueller. Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression. European Radiology 2010; 20(4): 877 doi: 10.1007/s00330-009-1610-4
|
9 |
Bradford J. Wood, Julia K. Locklin, Anand Viswanathan, Jochen Kruecker, Dieter Haemmerich, Juan Cebral, Ariela Sofer, Ruida Cheng, Evan McCreedy, Kevin Cleary, Matthew J. McAuliffe, Neil Glossop, Jeff Yanof. Technologies for Guidance of Radiofrequency Ablation in the Multimodality Interventional Suite of the Future. Journal of Vascular and Interventional Radiology 2007; 18(1): 9 doi: 10.1016/j.jvir.2006.10.013
|
10 |
Yi-You Chiou, Yi-Hong Chou. Radiofrequency Ablation of Hepatocellular Carcinoma. Journal of Medical Ultrasound 2008; 16(4): 272 doi: 10.1016/S0929-6441(09)60005-9
|
11 |
Dong Kyu Kim, Joon Ho Kwon, Jong Yun Won, Kichang Han, Gyoung Min Kim, Man-Deuk Kim, Do Yun Lee. Ablation Volume Measurement After Percutaneous Cryoablation Using a Two-cryo-probe Technique for Small Hepatocellular Carcinomas. CardioVascular and Interventional Radiology 2019; 42(2): 220 doi: 10.1007/s00270-018-2084-z
|
12 |
Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, Floriane Sellier, Paul Castellani, Valerie Oules, Herve Perrier, Gaëlle Lefolgoc, Bernard Pol, Manuela Campanile, Olivier Bayle, Patrick Beaurain, Olivier Monnet, Marc Bourlière. Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals: a case–control study. European Journal of Gastroenterology & Hepatology 2018; 30(4): 368 doi: 10.1097/MEG.0000000000001082
|
13 |
Chang-Hsien Liu, Kambadakone R. Avinssh, Debra A. Gervais, Dushyant V. Sahani. Interventional Radiological Treatment of Liver Tumors. 2008; : 44 doi: 10.1017/CBO9780511575433.005
|
14 |
Christopher Dobbins, Catriona Brennan, Simon Wemyss-Holden, John Cockburn, Guy Maddern. Bimodal Electric Tissue Ablation-Long Term Studies of Morbidity and Pathological Change. Journal of Surgical Research 2008; 148(2): 251 doi: 10.1016/j.jss.2007.09.008
|
15 |
G. Garcea, S.L. Ong, G.J. Maddern. Inoperable colorectal liver metastases: A declining entity?. European Journal of Cancer 2008; 44(17): 2555 doi: 10.1016/j.ejca.2008.07.028
|
16 |
Constantinos T. Sofocleous, Sandeep Garg, Lydia M. Petrovic, Mithat Gonen, Elena N. Petre, David S. Klimstra, Stephen B. Solomon, Karen T. Brown, Lynn A. Brody, Ann M. Covey, Ronald P. DeMatteo, Lawrence Schwartz, Nancy E. Kemeny. Ki-67 is a Prognostic Biomarker of Survival after Radiofrequency Ablation of Liver Malignancies. Annals of Surgical Oncology 2012; 19(13): 4262 doi: 10.1245/s10434-012-2461-9
|
17 |
Yusuke Kawamura, Kenji Ikeda, Shunichiro Fujiyama, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Yasuji Arase, Hiromitsu Kumada. Potential of a no‐touch pincer ablation procedure that uses a multipolar radiofrequency ablation system to prevent intrasubsegmental recurrence of small and single hepatocellular carcinomas. Hepatology Research 2017; 47(10): 1008 doi: 10.1111/hepr.12838
|
18 |
Christopher Dobbins, Simon A. Wemyss-Holden, John Cockburn, Guy J. Maddern. Bimodal Electric Tissue Ablation-Modified Radiofrequency Ablation with a Le Veen Electrode in a Pig Model. Journal of Surgical Research 2008; 144(1): 111 doi: 10.1016/j.jss.2007.03.066
|
19 |
Naoki Yamamoto, Keiichi Okano, Yoshio Kushida, Akihiro Deguchi, Shinichi Yachida, Yasuyuki Suzuki. Clinicopathology of recurrent hepatocellular carcinomas after radiofrequency ablation treated with salvage surgery. Hepatology Research 2014; 44(11): 1062 doi: 10.1111/hepr.12223
|
20 |
Yu‐Hung Su, Kwai‐Fong Ng, Ming‐Chin Yu, Ting‐Jung Wu, Ta‐Sen Yeh, Wei‐Chen Lee, Yong‐Shiang Lin, Tsung‐Han Hsieh, Chun‐Yen Lin, Chau‐Ting Yeh, Tse‐Ching Chen. Impact of epidermal growth factor receptor protein and gene alteration on Taiwanese hepatocellular carcinomas. Journal of Gastroenterology and Hepatology 2015; 30(9): 1397 doi: 10.1111/jgh.12944
|
21 |
Haruyuki Takaki, Koichiro Yamakado, Atsuhiro Nakatsuka, Hiroyuki Fuke, Kazumoto Murata, Katsuya Shiraki, Kan Takeda. Radiofrequency Ablation Combined with Chemoembolization for the Treatment of Hepatocellular Carcinomas 5 cm or Smaller: Risk Factors for Local Tumor Progression. Journal of Vascular and Interventional Radiology 2007; 18(7): 856 doi: 10.1016/j.jvir.2007.04.022
|
22 |
Takao Hiraki, Hidefumi Mimura, Hideo Gobara, Yoshifumi Sano, Hiroyasu Fujiwara, Hiroshi Date, Susumu Kanazawa. Repeat Radiofrequency Ablation for Local Progression of Lung Tumors: Does It Have a Role in Local Tumor Control?. Journal of Vascular and Interventional Radiology 2008; 19(5): 706 doi: 10.1016/j.jvir.2007.12.441
|
23 |
Heather Higgins, David L. Berger. RFA for Liver Tumors: Does It Really Work?. The Oncologist 2006; 11(7): 801 doi: 10.1634/theoncologist.11-7-801
|
24 |
Yusuke Kawamura, Kenji Ikeda, Miharu Hirakawa, Hiromi Yatsuji, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Masahiro Kobayashi, Satoshi Saitoh, Fumitaka Suzuki, Yoshiyuki Suzuki, Yasuji Arase, Hiromitsu Kumada. New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma. Hepatology Research 2010; 40(10): 1006 doi: 10.1111/j.1872-034X.2010.00703.x
|
25 |
Katsutoshi Sugimoto, Fuminori Moriyasu, Naohisa Kamiyama, Ryo Metoki, Masahiko Yamada, Yasuharu Imai, Hiroko Iijima. Analysis of morphological vascular changes of hepatocellular carcinoma by microflow imaging using contrast‐enhanced sonography. Hepatology Research 2008; 38(8): 790 doi: 10.1111/j.1872-034X.2008.00331.x
|
26 |
Shih-Wei Lai, Kuan-Fu Liao, Chung-Yi Lin, Chi-Hung Huang, Yi-Ying Lin. Risk Factors of Recurrence After Curative Resection of Hepatocellular Carcinoma in Taiwan. The American Journal of the Medical Sciences 2011; 341(4): 301 doi: 10.1097/MAJ.0b013e3181ff5d93
|
27 |
Aziz Ahmad, Steven L. Chen, Maihgan A. Kavanagh, David P. Allegra, Anton J. Bilchik. Radiofrequency Ablation of Hepatic Metastases from Colorectal Cancer: Are Newer Generation Probes Better?. The American Surgeon™ 2006; 72(10): 875 doi: 10.1177/000313480607201007
|
28 |
Brent D. Weinberg, Ravi B. Patel, Agata A. Exner, Gerald M. Saidel, Jinming Gao. Modeling doxorubicin transport to improve intratumoral drug delivery to RF ablated tumors. Journal of Controlled Release 2007; 124(1-2): 11 doi: 10.1016/j.jconrel.2007.08.023
|
29 |
Toshifumi Wakai, Yoshio Shirai, Takeshi Suda, Naoyuki Yokoyama, Jun Sakata, Pauldion V Cruz, Hirokazu Kawai, Yasunobu Matsuda, Masashi Watanabe, Yutaka Aoyagi, Katsuyoshi Hatakeyama. Long-term outcomes of hepatectomy <i>vs</i> percutaneous ablation for treatment of hepatocellular carcinoma ≤ 4 cm. World Journal of Gastroenterology 2006; 12(4): 546-552 doi: 10.3748/wjg.v12.i4.546
|
30 |
Qi‐Feng Chen, Tao Huang, Qi‐Jiao Si‐Tu, Peihong Wu, Lujun Shen, Wang Li, Zilin Huang. Analysis of competing endogenous RNA network identifies a poorly differentiated cancer‐specific RNA signature for hepatocellular carcinoma. Journal of Cellular Biochemistry 2020; 121(3): 2303 doi: 10.1002/jcb.29454
|
31 |
Akitoshi Douhara, Tadashi Namisaki, Kei Moriya, Mitsuteru Kitade, Kosuke Kaji, Hideto Kawaratani, Kosuke Takeda, Yasushi Okura, Hiroaki Takaya, Ryuichi Noguchi, Norihisa Nishimura, Kenichiro Seki, Shinya Sato, Yasuhiko Sawada, Junichi Yamao, Akira Mitoro, Masakazu Uejima, Tsuyoshi Mashitani, Naotaka Shimozato, Soichiro Saikawa, Keisuke Nakanishi, Masanori Furukawa, Takuya Kubo, Hitoshi Yoshiji. Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization. Oncology Letters 2017; 14(3): 3028 doi: 10.3892/ol.2017.6489
|
32 |
Tomoki Ryu, Yuko Takami, Yoshiyuki Wada, Masaki Tateishi, Takanobu Hara, Munehiro Yoshitomi, Seiya Momosaki, Kotaro Yasumori, Hideki Saitsu, Koji Okuda. A Clinical Scoring System for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma Within the Milan Criteria. Journal of Gastrointestinal Surgery 2019; 23(4): 779 doi: 10.1007/s11605-019-04134-y
|
33 |
Mohammed Fawzy Montasser, Mohamed Kamal Shaker, Ashraf M Albreedy, Iman Fawzy Montasser, Ahmed El Dorry. Risk factors for early intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma in Egyptian patients. Journal of Digestive Diseases 2014; 15(12): 676 doi: 10.1111/1751-2980.12190
|
34 |
H. FUKE, K. SUGIMOTO, K. SHIRAKI, J. TANAKA, T. BEPPU, K. YONEDA, N. YAMAMOTO, K. ITO, H. TAKAKI, A. NAKATSUKA, K. YAMAKADO, K. TAKEDA, Y. TAKEI. Predictive factors for distant recurrence of HCV‐related hepatocellular carcinoma after radiofrequency ablation combined with chemoembolization. Alimentary Pharmacology & Therapeutics 2008; 27(12): 1253 doi: 10.1111/j.1365-2036.2008.03627.x
|
35 |
Ryo Shimizu, Yoshiyuki Ida, Masayuki Kitano. Predicting Outcome after Percutaneous Ablation for Early-Stage Hepatocellular Carcinoma Using Various Imaging Modalities. Diagnostics 2023; 13(19): 3058 doi: 10.3390/diagnostics13193058
|
36 |
K. Jiang, J. Dong, W. Zhang, Y. Liu, M. Su, X. Zhao, J. Wang, M. Yao, Z. Huang. Effect of one-off complete tumor radiofrequency ablation on liver function and postoperative complication in small hepatocellular carcinoma. European Journal of Surgical Oncology 2014; 40(5): 576 doi: 10.1016/j.ejso.2013.12.004
|
37 |
Hidetoshi Nitta, Shigeki Nakagawa, Takayoshi Kaida, Kota Arima, Takaaki Higashi, Katsunobu Taki, Hirohisa Okabe, Hiromitsu Hayashi, Daisuke Hashimoto, Akira Chikamoto, Takatoshi Ishiko, Toru Beppu, Hideo Baba. Pre-treatment double- or triple-positive tumor markers are predictive of a poor outcome for patients undergoing radiofrequency ablation for hepatocellular carcinoma. Surgery Today 2017; 47(3): 375 doi: 10.1007/s00595-016-1385-6
|
38 |
Oliver F. Bathe, Houman Mahallati, Francis Sutherland, Elijah Dixon, Janice Pasieka, Garnette Sutherland. Complex hepatic surgery aided by a 1.5-tesla moveable magnetic resonance imaging system. The American Journal of Surgery 2006; 191(5): 598 doi: 10.1016/j.amjsurg.2006.02.008
|
39 |
Nazario Portolani, Gian Luca Baiocchi, Arianna Coniglio, Luigi Grazioli, Eleonora Frassi, Federico Gheza, Stefano Maria Giulini. Sequential multidisciplinary treatment of hepatocellular carcinoma: The role of surgery as rescue therapy for failure of percutaneous ablation therapies. Journal of Surgical Oncology 2009; 100(7): 580 doi: 10.1002/jso.21375
|
40 |
Yusuke Kawamura, Kenji Ikeda, Taito Fukushima, Tasuku Hara, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Yasuji Arase, Hiromitsu Kumada. Potential of a no‐touch pincer ablation procedure for small hepatocellular carcinoma that uses a multipolar radiofrequency ablation system: An experimental animal study. Hepatology Research 2014; 44(12): 1234 doi: 10.1111/hepr.12240
|
41 |
Hee Young Lee, Hyunchul Rhim, Min Woo Lee, Young-sun Kim, Dongil Choi, Min Jung Park, Young Kon Kim, Seong Hyun Kim, Hyo Keun Lim. Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors. European Radiology 2013; 23(1): 190 doi: 10.1007/s00330-012-2561-8
|
42 |
Dening Ma, Xinyi Gao, Zhuo Liu, Xingang Lu, Haixing Ju, Ning Zhang. Exosome‐transferred long non‐coding RNA ASMTL‐AS1 contributes to malignant phenotypes in residual hepatocellular carcinoma after insufficient radiofrequency ablation. Cell Proliferation 2020; 53(9) doi: 10.1111/cpr.12795
|
43 |
Constantinos T. Sofocleous, Rodrigo G. Nascimento, Lydia M. Petrovic, David S. Klimstra, Mithat Gonen, Karen T. Brown, Lynn A. Brody, Anne M. Covey, Raymond H. Thornton, Yuman Fong, Stephen B. Solomon, Lawrence H. Schwartz, Ronald P. DeMatteo, George I. Getrajdman. Histopathologic and Immunohistochemical Features of Tissue Adherent to Multitined Electrodes after RF Ablation of Liver Malignancies Can Help Predict Local Tumor Progression: Initial Results. Radiology 2008; 249(1): 364 doi: 10.1148/radiol.2491071752
|
44 |
Debra A. Gervais, S. Nahum Goldberg, Daniel B. Brown, Michael C. Soulen, Steven F. Millward, Dheeraj K. Rajan. Society of Interventional Radiology Position Statement on Percutaneous Radiofrequency Ablation for the Treatment of Liver Tumors. Journal of Vascular and Interventional Radiology 2009; 20(7): S342 doi: 10.1016/j.jvir.2009.04.029
|
45 |
Takao Hiraki, Jun Sakurai, Toshihide Tsuda, Hideo Gobara, Yoshifumi Sano, Takashi Mukai, Soichiro Hase, Toshihiro Iguchi, Hiroyasu Fujiwara, Hiroshi Date, Susumu Kanazawa. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors. Cancer 2006; 107(12): 2873 doi: 10.1002/cncr.22333
|
46 |
|
47 |
Kosaku Moribata, Hideyuki Tamai, Naoki Shingaki, Yoshiyuki Mori, Tatsuya Shiraki, Shotaro Enomoto, Hisanobu Deguchi, Kazuki Ueda, Izumi Inoue, Takao Maekita, Mikitaka Iguchi, Masao Ichinose. Ultrasonogram of hepatocellular carcinoma is associated with outcome after radiofrequency ablation. World Journal of Hepatology 2012; 4(12): 374 doi: 10.4254/wjg.v4.i12.374
|
48 |
Yusuke Kawamura, Kenji Ikeda, Yuya Seko, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Hiromitsu Kumada. Heterogeneous Type 4 Enhancement of Hepatocellular Carcinoma on Dynamic CT Is Associated With Tumor Recurrence After Radiofrequency Ablation. American Journal of Roentgenology 2011; 197(4): W665 doi: 10.2214/AJR.11.6843
|
49 |
Toru Beppu, Shigeki Nakagawa, Hidetoshi Nitta, Hirohisa Okabe, Takayoshi Kaida, Katsunori Imai, Hiromitsu Hayashi, Yuki Koga, Kunitaka Kuramoto, Daisuke Hashimoto, Yo-ichi Yamashita, Akira Chikamoto, Takatoshi Ishiko, Hideo Baba. The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2016.00055
|
50 |
Yoshiyuki Mori, Hideyuki Tamai, Naoki Shingaki, Kosaku Moribata, Hisanobu Deguchi, Kazuki Ueda, Izumi Inoue, Takao Maekita, Mikitaka Iguchi, Jun Kato, Masaki Terada, Masao Ichinose. Signal intensity of small hepatocellular carcinoma on apparent diffusion coefficient mapping and outcome after radiofrequency ablation. Hepatology Research 2015; 45(1): 75 doi: 10.1111/hepr.12311
|
51 |
JME Chua, YMP Lam, BS Tan, KH Tay, A Gogna, FG Irani, HGR, Lo, CW Too. Single-centre retrospective review of risk factors for local tumour progression and complications in radiofrequency ablation of 555 hepatic lesions. Singapore Medical Journal 2019; 60(4): 188 doi: 10.11622/smedj.2019036
|
52 |
Toshiro Masuda, Toru Beppu, Takatoshi Ishiko, Kei Horino, Yoshifumi Baba, Takao Mizumoto, Hiromitsu Hayashi, Hirohisa Okabe, Hasita Horlad, Koichi Doi, Kazutoshi Okabe, Hiroshi Takamori, Masahiko Hirota, Ken-Ichi Iyama, Hideo Baba. Intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy. Journal of Hepato-Biliary-Pancreatic Surgery 2008; 15(6): 589 doi: 10.1007/s00534-007-1288-4
|
53 |
Yusuke Kawamura, Kenji Ikeda, Junichi Shindoh, Yuta Kobayashi, Kayoko Kasuya, Shunichiro Fujiyama, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Yasuji Arase, Masaji Hashimoto, Hiromitsu Kumada. No‐touch ablation in hepatocellular carcinoma has the potential to prevent intrasubsegmental recurrence to the same degree as surgical resection. Hepatology Research 2019; 49(2): 164 doi: 10.1111/hepr.13254
|
54 |
Samia Rekik, Manon Allaire, Annie Mumana, Erwan Guyot, Gisèle Nkontchou, Véronique Grando, Lorraine Blaise, Marianne Ziol, Pierre Nahon, Nathalie Ganne‐Carrié, Olivier Sutter, Olivier Seror, Jean‐Charles Nault. Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis. Journal of Gastroenterology and Hepatology 2020; 35(1): 142 doi: 10.1111/jgh.14763
|
55 |
Hitoshi Maruyama, Masanori Takahashi, Taro Shimada, Tadashi Sekimoto, Hidehiro Kamesaki, Fumihiko Kanai, Osamu Yokosuka. Pretreatment Microbubble-Induced Enhancement in Hepatocellular Carcinoma Predicts Intrahepatic Distant Recurrence After Radiofrequency Ablation. American Journal of Roentgenology 2013; 200(3): 570 doi: 10.2214/AJR.12.8999
|
56 |
Oliver F. Bathe, Kelly Warren Burak. Patient Surveillance After Cancer Treatment. 2013; : 169 doi: 10.1007/978-1-60327-969-7_31
|